Profilo
Russell E.
Phares was a Director of Advanced Proteome Therapeutics Corp.
He served as Chief Executive Officer of CooperVision Pharmaceuticals and Cooper Laboratories for 10 years.
Dr. Phares received a PhD in Pharmacy from Purdue University.
He was an Assistant Professor of Pharmacy at the University of Florida.
Precedenti posizioni note di Russell E. Phares
| Società | Posizione | Fine |
|---|---|---|
| ADVANCED PROTEOME THERAPEUTICS CORPORATION | Direttore/Membro del Consiglio | 11/10/2008 |
CooperVision, Inc.
 CooperVision, Inc. Medical SpecialtiesHealth Technology CooperVision, Inc. engages in the manufacture of contact lenses. It offers monthly, two-week and daily disposable contact lenses, all featuring advanced materials and optics. The firm’s products include MyDay; clariti 1day , Biofinity , Proclear and Avaira family. The company was founded in 1950 and is headquartered in Victor, NY. | Presidente | - |
| CooperVision Pharmaceuticals, Inc. | Presidente | - |
Formazione di Russell E. Phares
| Purdue University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ADVANCED PROTEOME THERAPEUTICS CORPORATION | Health Technology |
| Aziende private | 2 |
|---|---|
CooperVision, Inc.
CooperVision, Inc. Medical SpecialtiesHealth Technology CooperVision, Inc. engages in the manufacture of contact lenses. It offers monthly, two-week and daily disposable contact lenses, all featuring advanced materials and optics. The firm’s products include MyDay; clariti 1day , Biofinity , Proclear and Avaira family. The company was founded in 1950 and is headquartered in Victor, NY. | Health Technology |
| CooperVision Pharmaceuticals, Inc. |
- Borsa valori
- Insiders
- Russell E. Phares
